Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/12/13 → 03/11/16 |
Funding
- Actelion Pharmaceuticals US Incorporated: $5,573.37
A multi-center, open-label, single-arm, Phase 3b study of macitentan in patients with Pulmonary Arterial Hypertension to psychometrically validate the PAH-SYMPACT instrument
- Gibbons, William (PI)
- Mammen, Manoj (CoI)
Project: Research